Company intelligence / Profile preview

LinkDoc Technology

Ownership: Private
Development stage: Commercial

Overview

LinkDoc Technology has developed industry-leading technologies to curate high-quality real-world oncology patient datasets by integrating clinical, genomic, and outcomes information. Their platforms are used by over 300 oncology centers in China to support research-grade analytics for precision medicine. The company enables real-world evidence generation for pharmaceutical companies and supports digital therapeutics as well as clinical decision-making tools. No direct therapeutic or drug development programs reported.

Therapeutic areas: Critical CareOncology
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Collaborates with over 600 departments from more than 300 top oncology centers in China. No specific pharma partnerships named.

Beyond the preview

Go deeper on LinkDoc Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LinkDoc Technology.

Explore the full profile